Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters. - Wikidata - awgldk - TriplyDB

Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.

Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.

http://www.wikidata.org/entity/Q39505379

about

Oncolytic viral therapy for pancreatic cancer: current research and future directions Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Oncolytic virotherapy for pancreatic cancer.Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection.STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy.Experimental study of the mechanism of tolerance induction in dexamethasone-treated dendritic cells.HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy Novel therapies for pancreatic cancer: setbacks and progress The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors."Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.Recent advances in oncolytic virus design.Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives.Pancreatic cancer gene therapy: from molecular targets to delivery systems.Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5 Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model.Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model.Novel permissive murine immunocompetent orthotopic colon carcinoma model for comparison of the antitumoral and safety profiles of three Adv-TKs.Cyclophosphamide enhances antitumor efficacy of oncolytic adenovirus expressing uracil phosphoribosyltransferase (UPRT) in immunocompetent Syrian hamsters.A novel conditionally replicating adenoviral vector with dual expression of IL-24 and arresten inserted in E1 and the region between E4 and fiber for improved melanoma therapy.Oncolytic viruses: adenoviruses.Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation.Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck.Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy Evaluation of monocytes as carriers for armed oncolytic adenoviruses in murine and Syrian hamster models of cancer.Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts.Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus.Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2

P2860

Q27011439-335D379C-AF14-4703-9C77-7EF1D8704BA9 Q33906116-363C51C6-AE13-42B5-9CD3-0D2D809EFE9B Q35590996-F6350C93-7CB8-4621-A595-D0BBE88BCC67 Q35643823-392094F9-0725-449F-AE05-DC16557395A1 Q35751170-A39E7296-43EF-4AC9-A22D-8D8B774D6CE6 Q36306398-BE90B439-7B76-48A0-8C88-15DA907DA2FE Q36516599-E87C09AE-06DA-477E-AF26-28FD7D17D1DF Q37104963-75B47314-F2F1-4B3A-A635-12E34CFF1489 Q37107622-69CAFCDF-88C6-434B-AD9A-E0F9D97F34D5 Q37185117-35465BCE-976F-43AA-989B-C2FB85D3E368 Q37185367-4423E03A-849F-4204-A23C-5AE76FE63C81 Q37622288-4B61A98E-E103-4565-B164-CC9BDDD06BAE Q37733550-51BC6489-DE85-4DCF-9101-5EC7E699BB1B Q37865172-D2670234-3D2E-4516-A7CB-1BEF9B303950 Q37867584-ED400FA8-56D6-4446-9B49-CD9288B9FC23 Q38025696-E08A5C1A-149B-4F8B-B4D5-8FB765746966 Q38073096-04DEB5FA-79F6-439A-BB4E-642952419B81 Q38099680-D3F07CE5-0BD9-47D6-B2A1-B1E58FC6AACB Q38161331-19571D48-2FD8-40B6-A00A-EBFCF3B95866 Q38703318-6E5E5D4A-F3BE-4A24-93A8-4B1E221E44DC Q38714311-3C7147A3-A1FF-423F-BDE7-BFB9A446D385 Q38811582-A6A5FD35-1B37-49E6-94ED-C9B79B089BD0 Q38879452-83F88DF1-198F-402A-BB2E-0BEC1D365203 Q39135464-F698DD62-72DF-4BBF-9FCB-53FC85AFE2B3 Q39188023-ACDB0AE3-0060-43E2-B1A9-8CACB38B2356 Q39423631-FE21BFCB-E343-4FA7-B665-649BAF6F6AFF Q39432063-685DE416-560A-4732-ADAD-2067F8D2D98C Q40200208-DD429887-CF2B-43EE-9A28-D5A2FB1AE838 Q41218508-0F73B79F-E073-481B-85B8-79C8FB950970 Q41699675-234C5E6C-E8F9-4A8F-ABE1-92342BA61BE8 Q42370561-A93D2963-1E10-4E0E-B7B1-6C9490E752AE Q42412637-5AB1D8AC-3652-4CD2-AD38-7144B920EF9E Q45874251-22FC6F05-1D7D-4B2A-973F-A31FD1B71215 Q49963933-CF79AF20-E6F9-4785-AEC8-47E282D4B5B7 Q53883435-9E63521E-525B-45E6-B601-ABEF6F0E116F Q54959132-DA2F6010-2225-415C-A255-8157B697C9A4 Q58586410-02F4C8FC-E837-4285-ADC6-5E3D660659D4

P2860

Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.

http://www.wikidata.org/entity/Q39505379

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Treatment of pancreatic cancer ...... rleukin-12 in Syrian hamsters.

@en

Treatment of pancreatic cancer ...... rleukin-12 in Syrian hamsters.

@nl

type

label

Treatment of pancreatic cancer ...... rleukin-12 in Syrian hamsters.

@en

Treatment of pancreatic cancer ...... rleukin-12 in Syrian hamsters.

@nl

prefLabel

Treatment of pancreatic cancer ...... rleukin-12 in Syrian hamsters.

@en

Treatment of pancreatic cancer ...... rleukin-12 in Syrian hamsters.

@nl

P1433

Q39505379-F84C86B2-CC3D-4D94-B155-08077713E06F

P1476

Q39505379-A9D6E6B2-EE36-4835-AADB-DA1211F3739D

P2093

Q39505379-4D8F66E5-66A5-4313-8435-FF7EA411DAA6

Q39505379-58CFBAF7-5CA7-45AA-B4C2-D9E246B9E8DE

Q39505379-75A3ABBD-ACC9-49B7-8D3C-D235B204EBF3

Q39505379-C609A5AD-051C-47E8-9FEA-205467C8E6B3

Q39505379-D596EABE-22DE-4D22-B870-BFA31424E4E0

P2860

Q39505379-0E6E94ED-41BA-4AD0-9081-6C0AF64CA30D

Q39505379-2569AA6F-130E-4965-8790-64010B42261C

Q39505379-4187A3C5-9C61-46D5-B123-D565E5060223

Q39505379-42677F39-507C-4C54-B01C-D04DF77E60C3

Q39505379-47BFEB44-1320-4418-9451-2381A5808BCA

Q39505379-4D31FBA2-B9E2-4952-8951-67FC5B39817D

Q39505379-57541758-9333-44AA-9494-A9397F9851D3

Q39505379-60DEDE00-2E3C-4A4D-A866-6D4F07A89FE1

Q39505379-655BC8BB-928C-4479-8E21-85B43F899739

Q39505379-6939E153-EF34-4B5C-9F8A-7B5D43ADB9E8

P304

Q39505379-43278DCF-B506-4A9A-9F51-943118AED441

P31

Q39505379-50E694D8-C1A5-4197-BC1C-A7C0088F2AC7

P356

Q39505379-3CDF323A-416C-4B05-9234-B435C404B1B4

P433

Q39505379-A813FB9E-EF54-4E44-B0C8-0F5EE239E132

P478

Q39505379-F245BD3C-18A8-4E1F-B50E-07200584ED9B

P50

Q39505379-06FDE972-832A-4224-8C5E-8789B8C79F4D

Q39505379-1AA0B53A-9784-40F7-9B41-77D91E9918F0

Q39505379-EEE70A2E-4B2B-441A-B8B4-5D8711F6B53F

P577

Q39505379-460182FF-512F-4B8C-BAD6-1A58140C2867

P5875

Q39505379-2C713BD4-C782-4B5B-A0D8-3A1F6883D53C

P698

Q39505379-10B02B8F-F221-452B-9343-3DBCC33BEB22

P921

Q39505379-E027FB23-8372-45C8-8DD1-746648E93250

Q39505379-EF507DF8-D019-4F09-8113-987F2B78E890

Q39505379-b67a363a-a123-424b-a162-ace32aa297dc

P932

Q39505379-7D4464E3-7859-4906-A028-41FD35996EE6

P356

P1433

Molecular Therapy

P1476

Treatment of pancreatic cancer ...... erleukin-12 in Syrian hamsters

@en

P2093

Daniel Perez

http://www.w3.org/2001/XMLSchema#string

Gloria Gonzalez-Aseguinolaza

http://www.w3.org/2001/XMLSchema#string

Maria Bunuales

http://www.w3.org/2001/XMLSchema#string

Ruben Hernandez-Alcoceba

http://www.w3.org/2001/XMLSchema#string

Sergia Bortolanza

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation

Current developments in adenovirus-based cancer gene therapy

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

Modelling the molecular circuitry of cancer.

Hypoxic gene expression and metastasis.

Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

Oncolytic viral therapies - the clinical experience.

Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression.

Interleukin-12: biological properties and clinical application.

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma.

P304

614-622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2009.9

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Ortiz de Solórzano

P577

2009-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24021833

http://www.w3.org/2001/XMLSchema#string

P698

19223865

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

2835109

http://www.w3.org/2001/XMLSchema#string